Status:
COMPLETED
Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection
Lead Sponsor:
First Affiliated Hospital, Sun Yat-Sen University
Conditions:
Gastric Cancer After D2 Lymph Node Dissection
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
Gastric cancer radical surgery related complications are common.Somatostatin is a conventional medical therapy for bleeding.This study explore the effect of Somatostatin for Advanced Gastric Cancer Af...
Eligibility Criteria
Inclusion
- More than eighteen years old
- Gastric cancer diagnosed by pathological examination
- Be given informed consent
- Without diabetes/hyperthyroidism/Damages of functions of heart, liver and kidney/Systemic Infection/immunodeficiency
Exclusion
- Contraindication of vascular puncture operation
- Patients who refused to take part in the programe
- Poor compliance of treatment
- Malnutrition,BMI\<18
- with pancreatectomy
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT01914692
Start Date
January 1 2013
End Date
July 1 2013
Last Update
August 2 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.